Many hepatic pathophysiologies, including NAFLD, are associated with increased expression of FABP1, while its knockdown reduces hepatic triglyceride accumulation and lipid peroxidation [76]. The gene discussed is FABP1; the disease is metabolic dysfunction-associated steatotic liver disease.